Conduit Pharmaceuticals Inc. (CDT) — Financial Flexibility Index
Conduit Pharmaceuticals Inc. (CDT) has a Financial Flexibility Index of 0.01x as of March 2026. Free cash flow of $25.73 Million (operating CF $-18.67 Million minus capex $44.39 Million) represents 0% of total liabilities ($2.18 Billion). Also explore Conduit Pharmaceuticals Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Conduit Pharmaceuticals Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Conduit Pharmaceuticals Inc. across 5 annual periods. Check Conduit Pharmaceuticals Inc. (CDT) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Conduit Pharmaceuticals Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Conduit Pharmaceuticals Inc.. For the full company profile including market capitalisation, see Conduit Pharmaceuticals Inc. (CDT) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-13.15 Million | $-15.55 Million | $2.28 Billion | ▲ +99.3% |
| 2024 | -0.88x | $-9.63 Million | $-9.68 Million | $10.99 Million | ▲ +12.8% |
| 2023 | -1.01x | $-7.72 Million | $-7.72 Million | $7.68 Million | ▼ -348.0% |
| 2022 | -0.22x | $-2.27 Million | $-2.27 Million | $10.09 Million | ▲ +98.0% |
| 2021 | -11.17x | $-2.15 Million | $-2.15 Million | $192.51K | — |